Literature DB >> 20640180

Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients.

G Burckart1, T Starzl, L Williams, A Sanghvi, C Gartner, R Venkataramanan, B Zitelli, J Malatack, A Urbach, W Diven, R Ptachcinski, B Shaw, S Iwatsuki.   

Abstract

Entities:  

Year:  1985        PMID： 20640180      PMCID： PMC2904683     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Liquid-chromatographic determination of cyclosporin A in blood and plasma.

Authors:  R J Sawchuk; L L Cartier
Journal:  Clin Chem       Date:  1981-08       Impact factor: 8.327

2.  Cyclosporin A: correlation between HPLC and RIA serum levels.

Authors:  E Abisch; T Beveridge; A Gratwohl; W Niederberger; K Nussbaumer; P Schaub; B Speck; M Trapp
Journal:  Pharm Weekbl Sci       Date:  1982-06-25

3.  Intravenous cyclosporine kinetics in renal failure.

Authors:  F Follath; M Wenk; S Vozeh; G Thiel; F Brunner; R Loertscher; M Lemaire; K Nussbaumer; W Niederberger; A Wood
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875
  3 in total
  30 in total

1.  Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.

Authors:  M O Karlsson; A Lindberg-Freijs
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

2.  Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients.

Authors:  A B Jain; J J Fung; A G Tzakis; R Venkataramanan; K Abu-Elmagd; M Alessiani; J Reyes; W Irish; V Warty; S Mehta
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 3.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 4.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

5.  Cyclosporine measurement by FPIA, PC-RIA, and HPLC following liver transplantation.

Authors:  G J Burckart; A Jain; W Diven; R Venkataramanan; T E Starzl
Journal:  Transplant Proc       Date:  1990-06       Impact factor: 1.066

Review 6.  Cyclosporin pharmacokinetics in paediatric transplant recipients.

Authors:  G F Cooney; K Habucky; K Hoppu
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

7.  Effect of a stable analogue of prostacyclin on cyclosporine A-induced nephrotoxicity: morphological qualitative and quantitative studies.

Authors:  M Kobayashi; S Takaya; H Koie
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

8.  Cyclosporine trough concentration monitoring in liver transplant patients.

Authors:  G J Burckart; R J Ptachcinski; R Venkataramanan; S Iwatsuki; C Esquivel; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

9.  Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.

Authors:  G J Burckart; R Venkataramanan; R J Ptachcinski; T E Starzl; B P Griffith; T R Hakala; J T Rosenthal; R L Hardesty; S Iwatsuki; J Brady
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

10.  Pharmacokinetics of oral cyclosporin A in diabetic children and adolescents.

Authors:  C Misteli; E Rey; G Pons; M O Richard; P d'Athis; A Legrand; P Bougneres; G Olive
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.